HuagongsheHuagongshe Chemistry Print Report · For research reference only
7,8-Dimethoxy-3-[3-(methylamino)propyl]-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one → Ivabradine
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 7,8-Dimethoxy-3-[3-(methylamino)propyl]-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one | HCID 10017219 | — |
| Reactant | (7S)-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl methanesulphonate | HCID 86659917 | — |
| Product | Ivabradine | HCID 132999 | — |
Reaction Steps
By proceeding as in Example 5, starting from (7S)-(iodomethyl)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-triene (or from (7S)-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl methanesulphonate) and from 7,8-dimethoxy-3-[3-(methylamino)-propyl]-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one, there is obtained ivabradine base, which is then converted into its hydrochloride by following the procedure described in patent specification EP 0 534 859 (Example 2, Step E).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08415468B2 |
| Source dataset | uspto-grants-2013_04 |
| ORD ID | ord-41f2086f141e4e32b31fe1e90cc218ac |
| Source note | uspto-grants-2013_04 |